Methylene Blue Research Guide

Full name: Methylene Blue (Methylthioninium Chloride)

A century-old pharmaceutical repurposed as a mitochondrial enhancer and cognitive optimizer. At low doses, it acts as an electron carrier in the mitochondrial chain, boosting ATP production and providing neuroprotection. Increasingly popular in telemedicine longevity protocols.

How Methylene Blue Works

Acts as an alternative electron carrier in the mitochondrial electron transport chain, bypassing complex I-III blockades. Inhibits monoamine oxidase, tau aggregation, and provides antioxidant protection through auto-oxidation cycling.

Dosing Protocol

• Typical dose: 0.5-2 mg/kg
• Frequency: Daily or cycled
• Duration: Cycled: 2 weeks on, 1 week off
• Route: Oral solution or sublingual

Reported Benefits

• Mitochondrial energy boost
• Cognitive enhancement
• Neuroprotection
• Anti-aging at cellular level
• Mood improvement
• Memory support

Potential Side Effects

• Blue/green urine discoloration
• Blue-tinged skin at high doses
• GI upset
• Serotonin syndrome risk with SSRIs
• Headache

Research Citations

1. Low-dose methylene blue in cognitive aging (2022) - Improved fMRI-measured cerebral blood flow and memory task performance by 22% in healthy elderly adults.
2. Methylene blue as mitochondrial medicine (2021) - Demonstrated 30% increase in mitochondrial complex IV activity and reduced oxidative damage markers.

Related Cognitive & Nootropic Compounds

• Selank - Full Profile
• Semax - Full Profile
• Dihexa - Full Profile
• NSI-189 - Full Profile
• Cerebrolysin - Full Profile
• P21 - Full Profile

View full Methylene Blue profile with 3D molecule viewer →